AMGN240719C215000
- 85.35
- 0.000.00%
Amgen Newsroom
Unpacking the Latest Options Trading Trends in Amgen
Financial giants have made a conspicuous bearish move on Amgen. Our analysis of options history for Amgen (NASDAQ:AMGN) revealed 18 unusual trades.Delving into the details, we found 22% of traders
A Closer Look at Amgen's Options Market Dynamics
Investors with a lot of money to spend have taken a bullish stance on Amgen (NASDAQ:AMGN).And retail traders should know.We noticed this today when the trades showed up on publicly available options
Unusual Options Activity: CEG, SIRI and Others Attract Market Bets, CEG V/OI Ratio Reaches 124.3
EST Jul 15th Afternoon Delivery - In the last two hours of trading, 4 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $375
Jefferies analyst Michael Yee maintains $Amgen(AMGN.US)$ with a buy rating, and maintains the target price at $375.According to TipRanks data, the analyst has a success rate of 45.4% and a total
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
Two factors often determine stock prices in the long run: earnings and interest rates.
Morgan Stanley Sees $180B Patent Cliff, $380B Deal Capacity Fueling Biopharma M&A
Amgen Inc.'s (NASDAQ:AMGN) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 6.4% Over Last Week
Amgen (AMGN) Rises Higher Than Market: Key Facts
Express News | Amgen Inc - Issues Statement on Irs Notice Related to Horizon Acquisition
Express News | Live On CNBC, Kevin Simpson Announces Bought More Amgen
These Are the Weight Loss Drug Stocks With the Most Upside - SA Sentiment Survey
UBS Downgrades Amgen(AMGN.US) to Hold Rating, Raises Target Price to $337
UBS analyst Trung Huynh downgrades $Amgen(AMGN.US)$ to a hold rating, and adjusts the target price from $200 to $337.According to TipRanks data, the analyst has a success rate of 75.5% and a total
Express News | Amgen Shares Hit Record-High, Last up 1.1%
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Express News | Amgen Inc : UBS Raises Target Price to $337 From $307
This Weight Loss Stock Is the Best Alternative to Eli Lilly, Novo - SA Sentiment
Check Out What Whales Are Doing With AMGN
Investors with a lot of money to spend have taken a bullish stance on Amgen (NASDAQ:AMGN).And retail traders should know.We noticed this today when the trades showed up on publicly available options
Amgen Is Maintained at Equal-Weight by Morgan Stanley
Amgen Is Maintained at Equal-Weight by Morgan